Pharmacokinetics and pharmacodynamics of posaconazole

L Chen, EHJ Krekels, PE Verweij, JB Buil, CAJ Knibbe… - Drugs, 2020 - Springer
Posaconazole is typically used for preventing invasive yeast and mold infections such as
invasive aspergillosis in high-risk immunocompromised patients. The oral suspension was …

Model‐informed drug development for anti‐infectives: state of the art and future

CR Rayner, PF Smith, D Andes… - Clinical …, 2021 - Wiley Online Library
Model‐informed drug development (MIDD) has a long and rich history in infectious
diseases. This review describes foundational principles of translational anti‐infective …

Research priorities towards precision antibiotic therapy to improve patient care

ZP Bulman, SG Wicha, EI Nielsen, JR Lenhard… - The Lancet …, 2022 - thelancet.com
Antibiotic resistance presents an incessant threat to our drug armamentarium that
necessitates novel approaches to therapy. Over the past several decades, investigation of …

[HTML][HTML] Pharmacokinetic/pharmacodynamic models for time courses of antibiotic effects

IK Minichmayr, V Aranzana-Climent… - International Journal of …, 2022 - Elsevier
Pharmacokinetic/pharmacodynamic (PKPD) models have emerged as valuable tools for the
characterization and translation of antibiotic effects, and consequently for drug development …

[HTML][HTML] Digital microbiology

A Egli, J Schrenzel, G Greub - Clinical Microbiology and Infection, 2020 - Elsevier
Background Digitalization and artificial intelligence have an important impact on the way
microbiology laboratories will work in the near future. Opportunities and challenges lie …

Resist or perish: fate of a microbial population subjected to a periodic presence of antimicrobial

L Marrec, AF Bitbol - PLoS computational biology, 2020 - journals.plos.org
The evolution of antimicrobial resistance can be strongly affected by variations of
antimicrobial concentration. Here, we study the impact of periodic alternations of absence …

Quantifying the contribution of four resistance mechanisms to ciprofloxacin MIC in Escherichia coli: a systematic review

BCL van der Putten, D Remondini… - Journal of …, 2019 - academic.oup.com
Background Reviews assessing the genetic basis of ciprofloxacin resistance in Escherichia
coli have mostly been qualitative. However, to predict resistance phenotypes based on …

Pivotal role of translation in anti‐infective development

LE Friberg - Clinical Pharmacology & Therapeutics, 2021 - Wiley Online Library
The value of model‐based translation in drug discovery and development is now effectively
being recognized in many disease areas and among various stakeholders. Such …

A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro

O Clewe, L Aulin, Y Hu, ARM Coates… - Journal of …, 2016 - academic.oup.com
Objectives Mycobacterium tuberculosis can exist in different states in vitro, which can be
denoted as fast multiplying, slow multiplying and non-multiplying. Characterizing the natural …

In Vitro and In Vivo Antimicrobial Activities of Vancomycin and Rifampin against Elizabethkingia anophelis

IF Lin, CH Lai, SY Lin, CC Lee, NY Lee, PY Liu… - International journal of …, 2023 - mdpi.com
Elizabethkingia anophelis has emerged as a critical human pathogen, and a number of
isolated reports have described the successful treatment of Elizabethkingia infections with …